The company announced the new offering, which uses the Amazon cloud infrastructure to analyze and store data, at the annual Bio-IT World Conference and Expo, where a number of speakers debated the pros and cons of cloud-based bioinformatics options.
"The life science market seems to be adopting the cloud at a much faster rate than other industries, and I think part of that is due to the fact that large pharma in particular is comfortable with outsourcing everything they do that is not part of their core business," said Cycle Computing's CEO.
